Home » HEART PILL TO BE SOLD BY ITSELF
HEART PILL TO BE SOLD BY ITSELF
Reversing a strategy that had drawn criticism from doctors, Pfizer says that it will apply for approval to sell a promising new heart treatment as a standalone pill rather than only in combination with Lipitor, Pfizer's best-selling cholesterol treatment.
New
York Times
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May